GSK to cut 1,217 jobs in Wallonia, pivots to oncology from vaccines

GSK announced a restructuring plan affecting up to 1,217 jobs in Wallonia, its largest private employer in the region, as it shifts focus from vaccines to oncology. The move signals a strategic pivot that may impact vaccine production capacity and regional employment, with implications for GSK's operational footprint and Belgium's industrial base.